PLoS ONE (Jan 2022)

Persons tested for SAR-CoV-2 at a military treatment facility in Hawaii.

  • Javier Barranco-Trabi,
  • Stephen Morgan,
  • Seema Singh,
  • Jimmy Hill,
  • Alexander Kayatani,
  • Victoria Mank,
  • Holly Nesmith,
  • Heather Omara,
  • Louis Tripoli,
  • Michael Lustik,
  • Jennifer Masel,
  • Sharon Chi,
  • Viseth Ngauy

DOI
https://doi.org/10.1371/journal.pone.0263472
Journal volume & issue
Vol. 17, no. 2
p. e0263472

Abstract

Read online

Health inequalities based on race are well-documented, and the COVID-19 pandemic is no exception. Despite the advances in modern medicine, access to health care remains a primary determinant of health outcomes, especially for communities of color. African-Americans and other minorities are disproportionately at risk for infection with COVID-19, but this problem extends beyond access alone. This study sought to identify trends in race-based disparities in COVID-19 in the setting of universal access to care. Tripler Army Medical Center (TAMC) is a Department of Defense Military Treatment Facility (DoD-MTF) that provides full access to healthcare to active duty military members, beneficiaries, and veterans. We evaluated the characteristics of individuals diagnosed with SARS-CoV-2 infection at TAMC in a retrospective, case-controlled (1:1) study. Most patients (69%) had received a COVID-19 test within 3 days of symptom onset. Multivariable logistic regression analyses were used to identify factors associated with testing positive and to estimate adjusted odds ratios. African-American patients and patients who identified as "Other" ethnicities were two times more likely to test positive for SARS-CoV-2 relative to Caucasian patients. Other factors associated with testing positive include: younger age, male gender, previous positive test, presenting with >3 symptoms, close contact with a COVID-19 positive patient, and being a member of the US Navy. African-Americans and patients who identify as "Other" ethnicities had disproportionately higher rates of positivity of COVID-19. Although other factors contribute to increased test positivity across all patient populations, access to care does not appear to itself explain this discrepancy with COVID-19.